| 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192939495969798991001011021031041051061071081091101111121131141151161171181191201211221231241251261271281291301311321331341351361371381391401411421431441451461471481491501511521531541551561571581591601611621631641651661671681691701711721731741751761771781791801811821831841851861871881891901911921931941951961971981992002012022032042052062072082092102112122132142152162172182192202212222232242252262272282292302312322332342352362372382392402412422432442452462472482492502512522532542552562572582592602612622632642652662672682692702712722732742752762772782792802812822832842852862872882892902912922932942952962972982993003013023033043053063073083093103113123133143153163173183193203213223233243253263273283293303313323333343353363373383393403413423433443453463473483493503513523533543553563573583593603613623633643653663673683693703713723733743753763773783793803813823833843853863873883893903913923933943953963973983994004014024034044054064074084094104114124134144154164174184194204214224234244254264274284294304314324334344354364374384394404414424434444454464474484494504514524534544554564574584594604614624634644654664674684694704714724734744754764774784794804814824834844854864874884894904914924934944954964974984995005015025035045055065075085095105115125135145155165175185195205215225235245255265275285295305315325335345355365375385395405415425435445455465475485495505515525535545555565575585595605615625635645655665675685695705715725735745755765775785795805815825835845855865875885895905915925935945955965975985996006016026036046056066076086096106116126136146156166176186196206216226236246256266276286296306316326336346356366376386396406416426436446456466476486496506516526536546556566576586596606616626636646656666676686696706716726736746756766776786796806816826836846856866876886896906916926936946956966976986997007017027037047057067077087097107117127137147157167177187197207217227237247257267277287297307317327337347357367377387397407417427437447457467477487497507517527537547557567577587597607617627637647657667677687697707717727737747757767777787797807817827837847857867877887897907917927937947957967977987998008018028038048058068078088098108118128138148158168178188198208218228238248258268278288298308318328338348358368378388398408418428438448458468478488498508518528538548558568578588598608618628638648658668678688698708718728738748758768778788798808818828838848858868878888898908918928938948958968978988999009019029039049059069079089099109119129139149159169179189199209219229239249259269279289299309319329339349359369379389399409419429439449459469479489499509519529539549559569579589599609619629639649659669679689699709719729739749759769779789799809819829839849859869879889899909919929939949959969979989991000100110021003100410051006100710081009101010111012101310141015101610171018101910201021102210231024102510261027102810291030103110321033103410351036103710381039104010411042104310441045104610471048104910501051105210531054105510561057105810591060106110621063106410651066106710681069107010711072107310741075107610771078107910801081108210831084108510861087108810891090109110921093109410951096109710981099110011011102110311041105110611071108110911101111111211131114111511161117 |
- <!DOCTYPE html>
- <html lang="zh-CN">
- <head>
- <meta charset="UTF-8">
- <meta name="viewport" content="width=device-width, initial-scale=1.0">
- <meta name="description" content="心脑血管疾病科学循证科普——症状识别、疾病定义、发病原因与主动健康五步干预。含肠道菌群-TMAO轴、富氢水内皮修复、中国心血管流行病学数据。">
- <meta name="keywords" content="心脑血管疾病,动脉粥样硬化,胸痛,脑卒中,高血压,肠道菌群,TMAO,富氢水,主动健康,心血管预防">
- <meta property="og:title" content="心脑血管疾病的症状、病因与主动健康干预 — 科学循证">
- <meta property="og:description" content="中国心血管患病3.45亿。症状识别→疾病机制→危险因素→主动健康五步:提前识别、风险管控、主动干预、效果评估、持续优化。">
- <meta property="og:type" content="article">
- <title>心脑血管疾病 · 症-病-因与主动健康干预 · 浠艾福</title>
- <style>
- :root {
- --bg-card: #FFFFFF;
- --bg-alt: #f8f5ff;
- --text-primary: #1a1a2e;
- --text-secondary: #4a5568;
- --text-muted: #718096;
- --accent: #c0392b;
- --accent-light: #fdf2f2;
- --blue: #1a5276;
- --blue-light: #eaf4fb;
- --teal: #148f77;
- --teal-light: #e6fffa;
- --purple: #7d3c98;
- --purple-light: #f5eef8;
- --orange: #d35400;
- --orange-light: #fff4e6;
- --font: system-ui, -apple-system, "PingFang SC", "Microsoft YaHei", "Noto Sans SC", sans-serif;
- --max-width: 1080px;
- --shadow-card: 0 4px 24px rgba(0,0,0,0.08);
- --shadow-hover: 0 8px 40px rgba(0,0,0,0.12);
- --radius: 16px;
- }
- * { margin: 0; padding: 0; box-sizing: border-box; }
- html { scroll-behavior: smooth; }
- body {
- font-family: var(--font);
- font-size: 1rem;
- line-height: 1.8;
- color: var(--text-primary);
- background: #fff;
- -webkit-font-smoothing: antialiased;
- }
- /* HERO */
- .hero {
- position: relative;
- background: linear-gradient(135deg, #2d1b3d 0%, #4a1942 40%, #6b2d5b 100%);
- color: white;
- padding: 6rem 1.5rem 4rem;
- overflow: hidden;
- min-height: 58vh;
- display: flex;
- align-items: center;
- }
- .hero::before {
- content: '';
- position: absolute;
- inset: 0;
- background:
- radial-gradient(circle at 20% 30%, rgba(192,57,43,0.15) 0%, transparent 50%),
- radial-gradient(circle at 80% 70%, rgba(20,143,119,0.1) 0%, transparent 50%);
- }
- .hero-particles { position: absolute; inset: 0; overflow: hidden; pointer-events: none; }
- .particle {
- position: absolute;
- border-radius: 50%;
- background: rgba(255,255,255,0.1);
- animation: float 8s ease-in-out infinite;
- }
- .particle:nth-child(1) { width:4px;height:4px;left:10%;top:20%;animation-delay:0s; }
- .particle:nth-child(2) { width:8px;height:8px;left:25%;top:60%;animation-delay:1s;opacity:0.08; }
- .particle:nth-child(3) { width:5px;height:5px;left:45%;top:15%;animation-delay:2s; }
- .particle:nth-child(4) { width:3px;height:3px;left:65%;top:70%;animation-delay:0.5s; }
- .particle:nth-child(5) { width:7px;height:7px;left:80%;top:30%;animation-delay:3s;opacity:0.06; }
- .particle:nth-child(6) { width:4px;height:4px;left:15%;top:85%;animation-delay:1.5s; }
- .particle:nth-child(7) { width:9px;height:9px;left:55%;top:45%;animation-delay:2.5s;opacity:0.1; }
- @keyframes float {
- 0%,100% { transform: translateY(0) scale(1); opacity: 0.1; }
- 50% { transform: translateY(-30px) scale(1.5); opacity: 0.22; }
- }
- .hero-content {
- position: relative;
- z-index: 1;
- max-width: var(--max-width);
- margin: 0 auto;
- text-align: center;
- width: 100%;
- }
- .hero-badge {
- display: inline-flex;
- align-items: center;
- gap: 0.5rem;
- background: rgba(255,255,255,0.1);
- border: 1px solid rgba(255,255,255,0.2);
- backdrop-filter: blur(8px);
- padding: 0.4rem 1rem;
- border-radius: 100px;
- font-size: 0.85rem;
- margin-bottom: 1.5rem;
- }
- .hero h1 {
- font-size: clamp(1.8rem, 5vw, 3rem);
- font-weight: 800;
- margin-bottom: 1rem;
- letter-spacing: -0.02em;
- line-height: 1.25;
- }
- .hero h1 .accent { color: #e74c3c; }
- .hero-sub {
- font-size: clamp(1rem, 2vw, 1.15rem);
- color: rgba(255,255,255,0.8);
- max-width: 680px;
- margin: 0 auto 2rem;
- line-height: 1.7;
- }
- .hero-stats {
- display: flex;
- gap: 1.5rem;
- justify-content: center;
- flex-wrap: wrap;
- margin-top: 2rem;
- }
- .hero-stat {
- background: rgba(255,255,255,0.08);
- backdrop-filter: blur(8px);
- border: 1px solid rgba(255,255,255,0.1);
- border-radius: 12px;
- padding: 1rem 1.5rem;
- text-align: center;
- min-width: 120px;
- }
- .hero-stat .num { font-size: 1.9rem; font-weight: 800; color: #e74c3c; display: block; }
- .hero-stat .label { font-size: 0.82rem; color: rgba(255,255,255,0.7); margin-top: 0.2rem; }
- .scroll-hint {
- position: absolute;
- bottom: 2rem;
- left: 50%;
- transform: translateX(-50%);
- color: rgba(255,255,255,0.45);
- font-size: 0.78rem;
- text-align: center;
- animation: bounce 2s ease-in-out infinite;
- cursor: pointer;
- text-decoration: none;
- display: flex;
- flex-direction: column;
- align-items: center;
- gap: 0.3rem;
- }
- @keyframes bounce {
- 0%,100% { transform: translateX(-50%) translateY(0); }
- 50% { transform: translateX(-50%) translateY(8px); }
- }
- .scroll-arrow {
- width: 16px; height: 16px;
- border-right: 2px solid rgba(255,255,255,0.4);
- border-bottom: 2px solid rgba(255,255,255,0.4);
- transform: rotate(45deg);
- }
- /* NAV */
- .nav {
- position: sticky;
- top: 0;
- z-index: 100;
- background: rgba(255,255,255,0.96);
- backdrop-filter: blur(12px);
- border-bottom: 1px solid rgba(0,0,0,0.06);
- padding: 0.75rem 1.5rem;
- }
- .nav-inner {
- max-width: var(--max-width);
- margin: 0 auto;
- display: flex;
- align-items: center;
- justify-content: space-between;
- gap: 1rem;
- flex-wrap: wrap;
- }
- .nav-brand {
- font-weight: 700;
- font-size: 0.95rem;
- color: var(--accent);
- text-decoration: none;
- display: flex;
- align-items: center;
- gap: 0.4rem;
- }
- .nav-links {
- display: flex;
- gap: 0.3rem;
- flex-wrap: wrap;
- list-style: none;
- }
- .nav-links a {
- color: var(--text-secondary);
- text-decoration: none;
- font-size: 0.85rem;
- padding: 0.3rem 0.7rem;
- border-radius: 8px;
- transition: all 0.2s;
- }
- .nav-links a:hover { background: var(--accent-light); color: var(--accent); }
- .nav-links a.active { background: var(--accent-light); color: var(--accent); font-weight: 600; }
- /* LAYOUT */
- .container { max-width: var(--max-width); margin: 0 auto; padding: 0 1.5rem; }
- .section { padding: 4rem 0; border-bottom: 1px solid #eee; }
- .section:last-of-type { border-bottom: none; }
- .section-alt { background: var(--bg-alt); }
- .section-tag {
- display: inline-flex;
- align-items: center;
- gap: 0.4rem;
- font-size: 0.72rem;
- font-weight: 700;
- letter-spacing: 0.1em;
- text-transform: uppercase;
- color: var(--accent);
- margin-bottom: 0.75rem;
- }
- .section-tag.purple { color: var(--purple); }
- .section-tag.teal { color: var(--teal); }
- .section-tag.blue { color: var(--blue); }
- .section-tag.orange { color: var(--orange); }
- .section-tag.green { color: var(--teal); }
- .section-title {
- font-size: clamp(1.4rem, 3vw, 2.1rem);
- font-weight: 800;
- margin-bottom: 1rem;
- line-height: 1.3;
- }
- .section-intro {
- font-size: 1.05rem;
- color: var(--text-secondary);
- margin-bottom: 2rem;
- max-width: 820px;
- line-height: 1.85;
- }
- /* GRID */
- .grid-2 { display: grid; grid-template-columns: 1fr 1fr; gap: 1.5rem; }
- .grid-3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1.5rem; }
- @media (max-width: 768px) { .grid-2, .grid-3 { grid-template-columns: 1fr; } }
- /* CARDS */
- .card {
- background: var(--bg-card);
- border-radius: var(--radius);
- padding: 1.75rem;
- box-shadow: var(--shadow-card);
- border: 1px solid rgba(0,0,0,0.04);
- transition: transform 0.2s, box-shadow 0.2s;
- }
- .card:hover { transform: translateY(-2px); box-shadow: var(--shadow-hover); }
- .card-icon { font-size: 2.4rem; margin-bottom: 0.75rem; display: block; }
- .card h3 { font-size: 1.1rem; font-weight: 700; margin-bottom: 0.6rem; }
- .card p { color: var(--text-secondary); font-size: 0.92rem; line-height: 1.75; }
- .card-accent { border-left: 4px solid var(--accent); }
- .card-blue { border-left: 4px solid var(--blue); }
- .card-teal { border-left: 4px solid var(--teal); }
- .card-purple { border-left: 4px solid var(--purple); }
- .card-orange { border-left: 4px solid var(--orange); }
- /* STAT ROW */
- .stat-row { display: flex; gap: 1.5rem; flex-wrap: wrap; margin: 1.5rem 0; }
- .stat-block {
- flex: 1;
- min-width: 110px;
- background: var(--bg-alt);
- border-radius: 12px;
- padding: 1.1rem 1.25rem;
- text-align: center;
- }
- .stat-block .number { font-size: 1.7rem; font-weight: 800; color: var(--accent); display: block; }
- .stat-block .number.blue { color: var(--blue); }
- .stat-block .number.teal { color: var(--teal); }
- .stat-block .number.purple { color: var(--purple); }
- .stat-block .number.orange { color: var(--orange); }
- .stat-block .unit { font-size: 0.72rem; color: var(--text-muted); display: block; margin-top: 0.15rem; }
- .stat-block .desc { font-size: 0.82rem; color: var(--text-secondary); margin-top: 0.35rem; }
- /* EVIDENCE BOX */
- .evidence-box {
- background: linear-gradient(135deg, #fdf2f2 0%, #fff9f0 100%);
- border: 1px solid rgba(192,57,43,0.12);
- border-radius: 12px;
- padding: 1.4rem 1.7rem;
- margin: 1.75rem 0;
- position: relative;
- overflow: hidden;
- }
- .evidence-box::before {
- content: '🔬';
- position: absolute;
- top: -0.5rem;
- right: 1rem;
- font-size: 3.5rem;
- opacity: 0.06;
- }
- .evidence-box.blue {
- background: linear-gradient(135deg, #eaf4fb 0%, #e8f4f8 100%);
- border-color: rgba(26,82,118,0.12);
- }
- .evidence-box.green {
- background: linear-gradient(135deg, #e6fffa 0%, #f0fff4 100%);
- border-color: rgba(20,143,119,0.12);
- }
- .evidence-box.purple {
- background: linear-gradient(135deg, #f5eef8 0%, #faf5ff 100%);
- border-color: rgba(125,60,152,0.12);
- }
- .evidence-box-header { display: flex; align-items: center; gap: 0.4rem; margin-bottom: 0.65rem; flex-wrap: wrap; }
- .evidence-box-title { font-weight: 700; font-size: 0.97rem; color: var(--accent); }
- .evidence-box.blue .evidence-box-title { color: var(--blue); }
- .evidence-box.green .evidence-box-title { color: var(--teal); }
- .evidence-box.purple .evidence-box-title { color: var(--purple); }
- .evidence-box p { color: var(--text-secondary); font-size: 0.92rem; line-height: 1.75; margin-bottom: 0.4rem; }
- .evidence-box p:last-child { margin-bottom: 0; }
- .ev-tag {
- display: inline-block;
- font-size: 0.68rem;
- font-weight: 700;
- padding: 0.18rem 0.55rem;
- border-radius: 100px;
- background: rgba(192,57,43,0.1);
- color: var(--accent);
- margin-right: 0.3rem;
- margin-top: 0.25rem;
- }
- .ev-tag.blue { background: rgba(26,82,118,0.1); color: var(--blue); }
- .ev-tag.green { background: rgba(20,143,119,0.1); color: var(--teal); }
- .ev-tag.purple { background: rgba(125,60,152,0.1); color: var(--purple); }
- .ev-tag.orange { background: rgba(211,84,0,0.1); color: var(--orange); }
- /* PROCESS STEPS */
- .process-steps { display: flex; flex-direction: column; gap: 1rem; margin: 1.5rem 0; }
- .process-step { display: flex; gap: 1.25rem; align-items: flex-start; }
- .step-num {
- flex-shrink: 0;
- width: 2rem; height: 2rem;
- background: var(--accent-light);
- color: var(--accent);
- border-radius: 50%;
- display: flex;
- align-items: center;
- justify-content: center;
- font-weight: 800;
- font-size: 0.88rem;
- }
- .step-num.blue { background: var(--blue-light); color: var(--blue); }
- .step-num.teal { background: var(--teal-light); color: var(--teal); }
- .step-num.purple { background: var(--purple-light); color: var(--purple); }
- .step-num.orange { background: var(--orange-light); color: var(--orange); }
- .step-num.green { background: var(--teal-light); color: var(--teal); }
- .step-content h4 { font-size: 0.98rem; font-weight: 700; margin-bottom: 0.28rem; color: var(--text-primary); }
- .step-content p { font-size: 0.88rem; color: var(--text-secondary); line-height: 1.7; }
- /* QUOTE */
- .quote-block {
- background: var(--bg-alt);
- border-left: 4px solid var(--accent);
- border-radius: 0 12px 12px 0;
- padding: 1.4rem 1.7rem;
- margin: 1.75rem 0;
- }
- .quote-block.blue { border-left-color: var(--blue); }
- .quote-block.green { border-left-color: var(--teal); }
- .quote-block.purple { border-left-color: var(--purple); }
- .quote-text { font-size: 1.02rem; font-style: italic; color: var(--text-secondary); line-height: 1.8; margin-bottom: 0.65rem; }
- .quote-source { font-size: 0.82rem; color: var(--text-muted); font-weight: 600; }
- /* LIST */
- .list-styled { list-style: none; padding: 0; margin: 1rem 0; }
- .list-styled li { padding: 0.45rem 0 0.45rem 1.7rem; position: relative; color: var(--text-secondary); font-size: 0.92rem; line-height: 1.7; }
- .list-styled li::before { content: '✔'; position: absolute; left: 0; color: var(--accent); font-weight: 700; font-size: 0.85rem; top: 0.45rem; }
- .list-styled.blue li::before { color: var(--blue); }
- .list-styled.green li::before { color: var(--teal); }
- /* TABLE */
- .table-wrap { overflow-x: auto; margin: 1.5rem 0; }
- table { width: 100%; border-collapse: collapse; font-size: 0.88rem; }
- th { background: var(--accent-light); color: var(--accent); padding: 0.7rem 1rem; text-align: left; font-weight: 700; white-space: nowrap; }
- th.blue { background: var(--blue-light); color: var(--blue); }
- th.teal { background: var(--teal-light); color: var(--teal); }
- th.purple { background: var(--purple-light); color: var(--purple); }
- td { padding: 0.7rem 1rem; border-bottom: 1px solid #eee; color: var(--text-secondary); vertical-align: top; }
- tr:last-child td { border-bottom: none; }
- tr:hover td { background: #fafafa; }
- /* STEP FLOW */
- .step-flow { display: flex; align-items: center; justify-content: center; flex-wrap: wrap; gap: 0.5rem; margin: 2rem 0; }
- .step-flow-item {
- background: white;
- border: 2px solid var(--accent);
- border-radius: 12px;
- padding: 0.85rem 1.4rem;
- text-align: center;
- min-width: 150px;
- box-shadow: var(--shadow-card);
- }
- .step-flow-item.blue { border-color: var(--blue); }
- .step-flow-item.teal { border-color: var(--teal); }
- .step-flow-item.purple { border-color: var(--purple); }
- .step-flow-item.orange { border-color: var(--orange); }
- .step-flow-item.green { border-color: var(--teal); }
- .step-flow-item .s-num { font-size: 0.72rem; font-weight: 700; color: var(--accent); display: block; margin-bottom: 0.2rem; }
- .step-flow-item.blue .s-num { color: var(--blue); }
- .step-flow-item.teal .s-num, .step-flow-item.green .s-num { color: var(--teal); }
- .step-flow-item.purple .s-num { color: var(--purple); }
- .step-flow-item.orange .s-num { color: var(--orange); }
- .step-flow-item .s-title { font-size: 0.9rem; font-weight: 700; color: var(--text-primary); display: block; }
- .step-flow-arrow { font-size: 1.2rem; color: #ccc; }
- /* CTA */
- .cta-section {
- background: linear-gradient(135deg, #2d1b3d 0%, #4a1942 100%);
- color: white;
- padding: 4rem 1.5rem;
- text-align: center;
- }
- .cta-section h2 { font-size: clamp(1.4rem, 3vw, 2rem); font-weight: 800; margin-bottom: 0.9rem; }
- .cta-section p { color: rgba(255,255,255,0.78); max-width: 580px; margin: 0 auto 2rem; font-size: 1rem; line-height: 1.7; }
- .cta-buttons { display: flex; gap: 1rem; justify-content: center; flex-wrap: wrap; }
- .btn { display: inline-flex; align-items: center; gap: 0.45rem; padding: 0.72rem 1.6rem; border-radius: 100px; font-size: 0.92rem; font-weight: 700; text-decoration: none; transition: all 0.2s; cursor: pointer; border: none; }
- .btn-primary { background: var(--accent); color: white; }
- .btn-primary:hover { background: #a93226; transform: translateY(-1px); }
- .btn-outline { background: transparent; color: white; border: 2px solid rgba(255,255,255,0.38); }
- .btn-outline:hover { border-color: white; background: rgba(255,255,255,0.1); }
- /* Footer styles replaced by shared js/footer.js */
- /* CITATIONS */
- .citations { background: #f8f8f8; border-top: 2px solid var(--accent); padding: 3rem 0; }
- .citation-card { background: white; border: 1px solid #eee; border-radius: 12px; padding: 1.2rem 1.5rem; margin-bottom: 0.9rem; }
- .citation-card .source { font-size: 0.83rem; font-weight: 700; color: var(--text-primary); margin-bottom: 0.35rem; }
- .citation-card .auth-row { display: flex; flex-wrap: wrap; gap: 0.35rem; margin-bottom: 0.4rem; }
- .auth-badge { display: inline-flex; align-items: center; gap: 0.25rem; font-size: 0.7rem; font-weight: 700; padding: 0.2rem 0.6rem; border-radius: 100px; background: #fde8e8; color: #c0392b; }
- .auth-badge.blue { background: #eaf4fb; color: #1a5276; }
- .auth-badge.green { background: #e6fffa; color: #148f77; }
- .auth-badge.purple { background: #f5eef8; color: #7d3c98; }
- .citation-card .findings { font-size: 0.85rem; color: var(--text-secondary); line-height: 1.65; margin-bottom: 0.35rem; }
- .citation-card .trans { font-size: 0.78rem; color: var(--text-muted); font-style: italic; margin-bottom: 0.35rem; }
- .citation-card .link { font-size: 0.78rem; color: var(--blue); text-decoration: none; }
- .citation-card .link:hover { text-decoration: underline; }
- .anchor { scroll-margin-top: 72px; }
- .shot-placeholder {
- background: linear-gradient(135deg,#f0f0f0,#e5e5e5);
- border-radius: 12px;
- display: flex;
- flex-direction: column;
- align-items: center;
- justify-content: center;
- min-height: 180px;
- color: #aaa;
- font-size: 0.85rem;
- gap: 0.4rem;
- margin: 1.25rem 0;
- }
- .shot-placeholder .shot-icon { font-size: 2.2rem; opacity: 0.35; }
- </style>
- </head>
- <body>
- <!-- HERO -->
- <section class="hero">
- <div class="hero-particles">
- <div class="particle"></div><div class="particle"></div><div class="particle"></div>
- <div class="particle"></div><div class="particle"></div><div class="particle"></div><div class="particle"></div>
- </div>
- <div class="hero-content">
- <div class="hero-badge">❤️ 科学循证 · 主动健康</div>
- <h1>心脑血管疾病<br><span class="accent">症·病·因与主动健康干预</span></h1>
- <p class="hero-sub">中国心血管现患3.45亿,高血压2.45亿。<br>理解症状信号 → 掌握核心病理 → 识别可控病因 → 建立主动健康五步干预闭环——<br>在基因给定的底牌上,通过科学干预改写疾病的结局。</p>
- <div class="hero-stats">
- <div class="hero-stat"><span class="num">3.45亿</span><span class="label">心血管现患人数</span></div>
- <div class="hero-stat"><span class="num">2.45亿</span><span class="label">高血压患者</span></div>
- <div class="hero-stat"><span class="num">458万</span><span class="label">年心血管病死亡</span></div>
- <div class="hero-stat"><span class="num">40%</span><span class="label">死亡归因占比</span></div>
- </div>
- </div>
- <a href="#symptoms" class="scroll-hint">
- <span>开始阅读</span>
- <div class="scroll-arrow"></div>
- </a>
- </section>
- <!-- NAV -->
- <nav class="nav">
- <div class="nav-inner">
- <a href="index.html" class="nav-brand">❤️ 浠艾福 · 主动健康学院</a>
- <ul class="nav-links">
- <li><a href="#symptoms">症</a></li>
- <li><a href="#disease">病</a></li>
- <li><a href="#causes">因</a></li>
- <li><a href="#proactive">主动健康五步</a></li>
- <li><a href="#citations">参考文献</a></li>
- </ul>
- </div>
- </nav>
- <!-- ══════════════════════════════════════════
- 症 · 症状识别
- ═══════════════════════════════════════════ -->
- <section class="section" id="symptoms">
- <div class="container">
- <div class="section-tag">🔍 症 · 症状识别</div>
- <h2 class="section-title">读懂身体的求救信号——心脑血管疾病的早期症状</h2>
- <p class="section-intro">
- 心脑血管疾病常被称"沉默的杀手"——高血压平时毫无症状,一旦发作却可致命;冠心病早期信号轻微,容易被忽视;脑卒中的FAST征象一旦出现需立即就医。理解这些症状,是主动健康的第一步:越早识别,干预窗口越宽,预后越好。
- </p>
- <div class="grid-2">
- <div class="card card-accent">
- <span class="card-icon">💔</span>
- <h3>冠心病的典型症状</h3>
- <p><strong>稳定型心绞痛:</strong>胸部压迫感、紧缩感或憋闷,多在运动、情绪激动、饱餐后出现,休息或含服硝酸甘油后2-5分钟内缓解。部位常为胸骨后,可放射至左肩、左臂、颈部、下颌。</p>
- <p style="margin-top:0.6rem;"><strong>不稳定性心绞痛:</strong>静息时也发作,或发作频率增加、持续时间延长、程度加重——这是心肌梗死的预警信号,需立即就医。</p>
- <p style="margin-top:0.6rem;"><strong>急性心肌梗死(AMI):</strong>持续性剧烈胸痛>20分钟,伴大汗淋漓、恶心呕吐、濒死感,含服硝酸甘油无效。老年、糖尿病患者的症状可能不典型(无痛性心梗),仅表现为呼吸困难或乏力。</p>
- </div>
- <div class="card card-blue">
- <span class="card-icon">🧠</span>
- <h3>脑卒中的早期信号(FAST原则)</h3>
- <p><strong>F · Face(面部)</strong>:笑时口角歪斜,歪向一侧;<strong>A · Arm(手臂)</strong>:双平举时一侧手臂下垂;<strong>S · Speech(语言)</strong>:说话含糊不清、听不懂别人说话;<strong>T · Time(时间)</strong>:立即拨打120,时间就是大脑。</p>
- <p style="margin-top:0.6rem;"><strong>其他预警信号:</strong>突发剧烈头痛(出血性脑卒中);突发单眼或双眼视物模糊;突发行走不稳、眩晕;突发意识丧失或抽搐。出现上述任何症状,即使短暂缓解也要立即就医——"小中风"(TIA,短暂性脑缺血发作)后7天内发生完全性卒中的风险高达10%。</p>
- </div>
- </div>
- <div class="grid-3" style="margin-top:1.5rem;">
- <div class="card card-teal">
- <span class="card-icon">🩺</span>
- <h3>高血压的"沉默"信号</h3>
- <p>大多数高血压患者<strong>毫无症状</strong>。约10%患者可能出现:头晕(尤其突然站立时)、头胀痛(后颈部、前额为著)、眼花、耳鸣、失眠、疲乏感。这些症状不特异,常被误认为"疲劳"或"年龄大了"。</p>
- <p style="margin-top:0.5rem;"><strong>警告:</strong>当高血压患者出现头痛、恶心呕吐、视物模糊、鼻出血时,往往提示已经发生高血压急症(血压>180/120mmHg伴靶器官损害),需紧急降压。</p>
- </div>
- <div class="card card-purple">
- <span class="card-icon">😵</span>
- <h3>心衰的典型表现</h3>
- <p><strong>左心衰(肺循环淤血):</strong>活动后呼吸困难(最早症状),夜间阵发性呼吸困难(睡到半夜憋醒,需坐起),端坐呼吸(平卧困难),咳嗽伴白色泡沫痰,严重时咯粉红色泡沫痰。</p>
- <p style="margin-top:0.5rem;"><strong>右心衰(体循环淤血):</strong>双下肢水肿(下午加重,早晨减轻或消退),腹部饱胀、食欲下降,肝颈静脉怒张,尿量减少。</p>
- </div>
- <div class="card card-orange">
- <span class="card-icon">⚡</span>
- <h3>血管堵塞的隐匿信号</h3>
- <p>动脉粥样硬化可累及全身血管:<strong>颈动脉狭窄</strong>可导致头晕、记忆力下降、一过性黑矇;<strong>肾动脉狭窄</strong>导致难以控制的高血压和肾功能异常;<strong>下肢动脉硬化闭塞</strong>导致行走后腿痛(间歇性跛行),休息后缓解。</p>
- <p style="margin-top:0.5rem;"><strong>勃起功能障碍(ED)</strong>:男性阴茎动脉直径仅1-2mm,比冠脉更细,ED可能是全身动脉粥样硬化的早期"窗口",是心血管疾病的独立预测因子。</p>
- </div>
- </div>
- <div class="evidence-box blue" style="margin-top:2rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">⚠️ 这些症状出现时,请立即就医</span>
- </div>
- <p>① 突发持续剧烈胸痛>15分钟,伴出汗、恶心、濒死感 → 疑似急性心肌梗死,呼叫120。<strong>研究显示,中国AMI患者从症状出现到入院平均耗时约3-4小时,延误治疗可导致心肌不可逆坏死。</strong></p>
- <p>② 突发口角歪斜、一侧肢体无力或麻木、言语不清 → 疑似脑卒中,溶栓时间窗(4.5小时内)和取栓时间窗(6小时内)错过将显著增加残疾风险。</p>
- <p>③ 突发剧烈头痛、呕吐、意识障碍 → 疑似脑出血,死亡率>40%,需立即CT确诊。</p>
- <p>④ 夜间呼吸困难、不能平卧、下肢重度水肿 → 急性心衰失代偿,需紧急住院治疗。</p>
- </div>
- </div>
- </section>
- <!-- ══════════════════════════════════════════
- 病 · 疾病定义与病理
- ═══════════════════════════════════════════ -->
- <section class="section section-alt" id="disease">
- <div class="container">
- <div class="section-tag purple">📖 病 · 疾病定义</div>
- <h2 class="section-title">心脑血管疾病:核心病理与流行病学</h2>
- <p class="section-intro">
- 心脑血管疾病是心脏和脑血管疾病的统称,涵盖冠心病、脑卒中、高血压、心力衰竭、风湿性心脏病、先天性心脏病及心肌病等。其共同核心病理基础是<strong>动脉粥样硬化</strong>——一种起始于内皮损伤、经数十年缓慢进展的慢性炎症性疾病。
- </p>
- <div class="stat-row">
- <div class="stat-block">
- <span class="number">3.45亿</span>
- <span class="unit">人</span>
- <span class="desc">中国心血管现患人数</span>
- </div>
- <div class="stat-block">
- <span class="number blue">2.45亿</span>
- <span class="unit">人</span>
- <span class="desc">高血压患者</span>
- </div>
- <div class="stat-block">
- <span class="number teal">1300万</span>
- <span class="unit">人/年</span>
- <span class="desc">新增脑卒中患者</span>
- </div>
- <div class="stat-block">
- <span class="number orange">458万</span>
- <span class="unit">人/年</span>
- <span class="desc">心血管病死亡人数</span>
- </div>
- </div>
- <p style="color:var(--text-muted);font-size:0.82rem;margin-bottom:1.5rem;">
- 数据来源:《中国心血管健康与疾病报告2024》|城乡居民死亡原因首位,农村死亡占比46.74%,城市44.26%
- </p>
- <div class="grid-2">
- <div class="card card-accent">
- <span class="card-icon">❤️</span>
- <h3>冠心病(CHD)</h3>
- <p>冠状动脉(为心肌供血的动脉)发生粥样硬化,导致管腔狭窄,心肌供血不足。中国冠心病患者约1139万。稳定型心绞痛在劳累时发作,休息或含硝酸甘油可缓解;不稳定型心绞痛在静息时也发作,反映斑块不稳定——这是急性心肌梗死的前兆。急性心肌梗死(AMI)是心肌供血完全中断导致心肌坏死,死亡率约5-10%(院外死亡占一半以上)。</p>
- </div>
- <div class="card card-blue">
- <span class="card-icon">🧠</span>
- <h3>脑卒中(Stroke)</h3>
- <p>分为缺血性(约占80%,脑梗死)和出血性(脑溢血)。缺血性脑卒中:脑血管被血栓或栓子堵塞导致脑组织缺血坏死,急性期可溶栓(4.5h内)或取栓(6-24h,需影像评估)。出血性脑卒中:脑血管破裂出血,脑组织直接受压损伤,死亡率>40%,主要病因是高血压性脑出血。中国脑卒中发病率约240/10万人年,显著高于发达国家。</p>
- </div>
- </div>
- <h3 style="font-size:1.1rem;font-weight:700;margin:2rem 0 1rem;">⚙️ 核心病理:动脉粥样硬化的四步进程</h3>
- <div class="process-steps">
- <div class="process-step">
- <div class="step-num purple">①</div>
- <div class="step-content">
- <h4>内皮功能障碍——疾病起点</h4>
- <p>正常内皮细胞分泌一氧化氮(NO),维持血管舒张、抑制血小板聚集、防止炎症细胞粘附。高血压、高血糖、吸烟、高LDL-C、氧化应激均可损伤内皮,使其通透性增加。LDL-C颗粒穿透内膜进入内皮下层,内皮细胞开始表达粘附分子(VCAM-1、ICAM-1),吸引单核细胞进入血管壁。这一阶段在青少年时期就已开始。</p>
- </div>
- </div>
- <div class="process-step">
- <div class="step-num purple">②</div>
- <div class="step-content">
- <h4>氧化应激与炎症激活——进展加速</h4>
- <p>进入内皮下层的LDL-C被活性氧(ROS)氧化为ox-LDL——高度促炎的致病分子。ox-LDL促使内皮细胞释放IL-1β、IL-6、TNF-α,激活NLRP3炎症小体。单核细胞分化为巨噬细胞,通过清道夫受体(SR-A、CD36)大量摄取ox-LDL,形成<strong>泡沫细胞</strong>——粥样硬化斑块的"种子"。</p>
- </div>
- </div>
- <div class="process-step">
- <div class="step-num purple">③</div>
- <div class="step-content">
- <h4>斑块形成与管腔狭窄</h4>
- <p>泡沫细胞堆积形成脂质核心,血管平滑肌细胞迁移增值并分泌胶原纤维形成纤维帽。斑块向管腔突出导致血流受阻。当管腔狭窄>70%时,安静状态下即可出现心肌供血不足(稳定型心绞痛)。斑块内新生血管形成增加斑块不稳定风险。</p>
- </div>
- </div>
- <div class="process-step">
- <div class="step-num purple">④</div>
- <div class="step-content">
- <h4>斑块不稳定与急性事件</h4>
- <p>斑块破裂是急性冠脉综合征和脑卒中的直接触发因素。不稳定斑块特征:薄纤维帽(<65μm)、大脂质核心、显著炎症细胞浸润。斑块破裂后脂质核心内容物暴露于血液,触发凝血级联反应形成血栓——完全阻断冠脉血流导致心肌梗死,或随血流堵塞脑动脉导致缺血性脑卒中。</p>
- </div>
- </div>
- </div>
- <div class="evidence-box" style="margin-top:2rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">📊 动脉粥样硬化的分子标志物</span>
- <span class="ev-tag">RCT证据</span>
- <span class="ev-tag blue">临床指标</span>
- </div>
- <p><strong>ox-LDL</strong>(氧化低密度脂蛋白):动脉粥样硬化的核心促炎分子,驱动泡沫细胞形成;<strong>hsCRP</strong>(超敏C反应蛋白):全身低度炎症标志物,预测心血管事件风险,参考值<1mg/L(低风险),1-3mg/L(中风险),>3mg/L(高风险);<strong>Lp(a)</strong>(脂蛋白a):由基因决定的独立风险因子,浓度>300mg/L时心血管风险显著升高;<strong>MMP-9</strong>(基质金属蛋白酶-9):降解纤维帽胶原,其水平升高提示斑块不稳定风险增加。</p>
- <p style="margin-top:0.5rem;color:var(--text-muted);font-style:italic;">CANTOS研究(NEJM 2017, doi:10.1056/NEJMoa1707914)首次证明:靶向IL-1β的Canakinumab抗炎治疗可降低心血管事件约15%(独立于降脂之外),开启了"心血管抗炎治疗"新纪元。</p>
- </div>
- <div class="quote-block green" style="margin-top:1.5rem;">
- <p class="quote-text">"动脉粥样硬化是一种血管老化疾病。它从童年期启动,经数十年潜伏,在中年出现症状,老年导致残疾和死亡。每一个阶段都存在干预机会——早期干预成本最低、获益最大。"</p>
- <span class="quote-source">— 《生理学评论》2023 · 心血管遗传学与动脉粥样硬化综述 · doi:10.1152/physrev.00024.2022</span>
- </div>
- </div>
- </section>
- <!-- ══════════════════════════════════════════
- 因 · 发病原因
- ═══════════════════════════════════════════ -->
- <section class="section" id="causes">
- <div class="container">
- <div class="section-tag orange">⚡ 因 · 发病原因</div>
- <h2 class="section-title">心脑血管疾病的九大可控病因</h2>
- <p class="section-intro">
- 理解"病因"不只是为了诊断,更是为了找到干预靶点。INTERHEART研究(全球52国,30000人)证实:<strong>90%以上的心肌梗死归因于9个可改变的危险因素</strong>。这意味着心脑血管疾病在很大程度上是"生活方式病"——基因给定底牌,行为决定结局。
- </p>
- <div class="evidence-box" style="margin-bottom:2rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">📊 INTERHEART研究:九大危险因素的归因危险度(PAR)</span>
- <span class="ev-tag">⚕️ 全球52国 · n=15000病例+15000对照</span>
- </div>
- <p>① 血脂异常(apoB/apoA1比值升高):<strong>PAR 49.2%</strong>——最大单一危险因素。<br>
- ② 吸烟:PAR 35.7%。<br>
- ③ 心理社会因素(压力/抑郁):PAR 16.5%。<br>
- ④ 糖尿病:PAR 25.7%。<br>
- ⑤ 高血压:PAR 25.0%。<br>
- ⑥ 腹型肥胖:PAR 20.1%。<br>
- ⑦ 水果蔬菜摄入不足:PAR 13.7%。<br>
- ⑧ 缺乏运动:PAR 12.2%。<br>
- ⑨ 过量饮酒:PAR 5.0%。</p>
- </div>
- <div class="grid-2">
- <div>
- <div class="card card-orange" style="margin-bottom:1.25rem;">
- <span class="card-icon">🧂</span>
- <h3>高钠饮食——高血压的头号推手</h3>
- <p>中国居民人均盐摄入约10.5g/天,是WHO推荐上限(5g)的2倍以上。高钠饮食直接升高血压,同时激活RAAS(肾素-血管紧张素-醛固酮系统),加重心脏负担,促进动脉粥样硬化。盐敏感者(人群中约30-50%)摄入高盐后血压升幅显著更大。</p>
- <p style="margin-top:0.5rem;"><strong>核心数据:</strong>每日盐摄入减少4.6g,收缩压平均降低约5mmHg(正常血压者)至约7mmHg(高血压患者)。TOHP研究15年随访显示,限盐组心血管事件风险降低约25%。</p>
- </div>
- <div class="card card-orange" style="margin-bottom:1.25rem;">
- <span class="card-icon">🍬</span>
- <h3>高血糖与糖尿病——血管的"甜蜜腐蚀"</h3>
- <p>糖尿病患者心血管病风险是非糖尿病者的2-4倍,约50%的糖尿病患者最终死于心血管病。高血糖通过多种机制损伤血管:AGEs(糖基化终末产物)积累、氧化应激增加、内皮NO合成减少、LDL糖化后更易被氧化。HbA1c每升高1%,心血管事件风险增加约18%。</p>
- <p style="margin-top:0.5rem;"><strong>重要窗口:</strong>"糖尿病前期"(空腹血糖受损或糖耐量异常)人群,心血管风险已比正常人升高约1.5倍,是早期干预的黄金时期。</p>
- </div>
- <div class="card card-orange">
- <span class="card-icon">🚬</span>
- <h3>吸烟——内皮的"直接攻击"</h3>
- <p>吸烟是心血管疾病独立且可逆的危险因素。烟草中尼古丁收缩血管、一氧化碳损伤内皮、促血小板活化、降低HDL-C。吸烟者心血管病风险比不吸烟者高2-3倍。</p>
- <p style="margin-top:0.5rem;"><strong>戒烟的惊人效果:</strong>戒烟1年,心血管病风险降低50%;戒烟5-15年,风险接近从不吸烟者。被动吸烟(二手烟)同样增加约25%的心血管病风险。</p>
- </div>
- </div>
- <div>
- <div class="card card-blue" style="margin-bottom:1.25rem;">
- <span class="card-icon">📦</span>
- <h3>腹型肥胖——代谢综合征的核心</h3>
- <p>BMI正常但腰围超标(男性≥90cm,女性≥85cm)的"正常体重代谢性肥胖"(MONW)人群,心血管风险显著升高。脂肪组织是活跃的内分泌器官,分泌IL-6、TNF-α等促炎因子,释放游离脂肪酸导致胰岛素抵抗,形成"代谢性炎症"状态。</p>
- <p style="margin-top:0.5rem;"><strong>代谢综合征:</strong>中心性肥胖+高血压+高血糖+血脂异常≥3项同时出现时,心血管病风险是无代谢综合征者的2-3倍。腰围每增加1cm,心血管事件风险增加约2%。</p>
- </div>
- <div class="card card-purple" style="margin-bottom:1.25rem;">
- <span class="card-icon">🥩</span>
- <h3>饱和脂肪酸与反式脂肪——直接促动脉硬化</h3>
- <p>饱和脂肪酸(主要来自红肉、全脂乳制品、棕榈油)升高LDL-C,促进动脉粥样硬化。反式脂肪(部分氢化植物油,油炸食品、烘焙食品中常见)作用更强——不仅升高LDL-C,还降低HDL-C、升高甘油三酯,是最强的心血管风险饮食因素。</p>
- <p style="margin-top:0.5rem;"><strong>WHO目标:</strong>2025年前在全球食品供应中消除工业反式脂肪。</p>
- </div>
- <div class="card card-teal">
- <span class="card-icon">😰</span>
- <h3>慢性心理压力——被忽视的心血管推手</h3>
- <p>慢性应激通过交感神经激活(↑儿茶酚胺)、HPA轴失调(↑皮质醇)升高血压、血糖和炎症水平。抑郁障碍患者心血管病风险增加约60%,机制涉及交感神经过度激活和血小板活化。</p>
- <p style="margin-top:0.5rem;"><strong>空气污染:</strong>PM2.5暴露每增加10μg/m³,心血管死亡率增加约0.5-1.0%,长期暴露可加速动脉粥样硬化进展。</p>
- </div>
- </div>
- </div>
- <h3 style="font-size:1.05rem;font-weight:700;margin:2rem 0 1rem;">🔬 肠道菌群:被低估的心血管"第三套影响因素"</h3>
- <div class="evidence-box purple" style="margin-bottom:2rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">🧫 肠道菌群-心血管轴:TMAO、SCFAs与胆汁酸系统</span>
- <span class="ev-tag purple">PMC9268449 · 系统综述</span>
- <span class="ev-tag green">新兴研究</span>
- </div>
- <p>人体肠道菌群携带约330万独特基因(人类基因组的150倍),被称为"第二基因组"。它们通过代谢产物深度参与心血管调控:</p>
- <p><strong>TMAO通路:</strong>富含肉碱(红肉、内脏)和胆碱(蛋黄、动物肝脏)的饮食→肠道菌群将其转化为TMA→TMA在肝脏经FMO3酶氧化为TMAO→TMAO促进动脉粥样硬化(加速泡沫细胞形成)、促进血小板活化和血栓形成。高TMAO水平人群心血管事件风险增加约60%。</p>
- <p><strong>SCFAs保护通路:</strong>膳食纤维(全谷物、蔬菜、水果)→肠道菌群发酵产生乙酸、丙酸、丁酸→SCFAs进入血液,作用于GPR41/43受体→降低血压(促进肾素分泌抑制)、减轻血管炎症、改善内皮功能、增加胰岛素敏感性。动物实验显示:高纤维饮食或补充丁酸盐可显著减轻动脉粥样硬化。</p>
- <p><strong>胆汁酸信号通路:</strong>初级胆汁酸(肝脏合成)→进入肠道后被菌群转化为次级胆汁酸→FXR和TGR5受体信号→调节糖脂代谢、抑制炎症、影响动脉粥样硬化进展。</p>
- </div>
- <div class="process-steps" style="margin-top:1rem;">
- <div class="process-step">
- <div class="step-num orange">💡</div>
- <div class="step-content">
- <h4>主动健康核心认知:病因可改变</h4>
- <p>心脑血管疾病的最重要"因"——高血压、高血糖、高血脂、吸烟、腹型肥胖、饮食失衡、缺乏运动、心理压力——全部是可改变的。即使遗传风险高,通过积极管理这些危险因素,同样可以大幅降低发病风险。建议每个家庭建立"心血管风险档案",记录各成员的危险因素现状和改善进度。</p>
- </div>
- </div>
- </div>
- </div>
- </section>
- <!-- ══════════════════════════════════════════
- 主动健康五步
- ═══════════════════════════════════════════ -->
- <section class="section section-alt" id="proactive">
- <div class="container">
- <div class="section-tag green">🌿 主动健康五步</div>
- <h2 class="section-title">从识别到优化:心脑血管疾病的主动健康干预闭环</h2>
- <p class="section-intro">
- "主动健康"的核心理念是:在疾病发生之前主动管理风险,在疾病发生之后主动参与康复。不是等生病了再治病,而是在疾病形成的每一个阶段都有主动干预的意识和工具。心脑血管疾病的主动健康分为五步:<strong>提前识别 → 风险管控 → 主动干预 → 效果评估 → 持续优化</strong>,形成一个永不中断的闭环。
- </p>
- <div class="step-flow">
- <div class="step-flow-item blue"><span class="s-num">STEP 01</span><span class="s-title">提前识别</span></div>
- <span class="step-flow-arrow">→</span>
- <div class="step-flow-item teal"><span class="s-num">STEP 02</span><span class="s-title">风险管控</span></div>
- <span class="step-flow-arrow">→</span>
- <div class="step-flow-item purple"><span class="s-num">STEP 03</span><span class="s-title">主动干预</span></div>
- <span class="step-flow-arrow">→</span>
- <div class="step-flow-item orange"><span class="s-num">STEP 04</span><span class="s-title">效果评估</span></div>
- <span class="step-flow-arrow">→</span>
- <div class="step-flow-item green"><span class="s-num">STEP 05</span><span class="s-title">持续优化</span></div>
- </div>
- <!-- STEP 01 -->
- <h3 style="font-size:1.15rem;font-weight:700;margin:2rem 0 1rem;color:var(--blue);">① 提前识别——在沉默期发现风险</h3>
- <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">
- 心脑血管疾病在早期(内皮功能障碍、动脉粥样硬化启动阶段)毫无症状。提前识别的目的是:在疾病"沉默期"发现风险,从而在最有效的干预窗口期采取行动。越早识别,逆转可能性越大,成本越低。
- </p>
- <div class="grid-2" style="margin-bottom:1.5rem;">
- <div>
- <div class="card card-blue">
- <h3>🔬 心血管风险评估工具</h3>
- <p><strong>China-PAR模型:</strong>中国自己的心血管风险评估模型,纳入年龄、性别、血压、胆固醇、血糖、BMI、腰围等指标,适合35-59岁人群。每1-2年评估一次。</p>
- <p style="margin-top:0.5rem;"><strong>Framingham风险评分(FRS):</strong>适合45岁以上人群,评估10年心血管事件风险,分为低危(<10%)、中危(10-20%)、高危(>20%)。</p>
- </div>
- <div class="card" style="margin-top:1.25rem;border-left:4px solid var(--blue);">
- <h3>📋 年度体检必查项目</h3>
- <table>
- <tr><th>项目</th><th>建议频率</th><th>意义</th></tr>
- <tr><td>血压</td><td>每次就诊/家庭自测</td><td>高血压早发现</td></tr>
- <tr><td>血脂四项</td><td>每年</td><td>动脉硬化核心指标</td></tr>
- <tr><td>空腹血糖+HbA1c</td><td>每年</td><td>糖尿病/前期筛查</td></tr>
- <tr><td>BMI+腰围</td><td>每年</td><td>肥胖评估</td></tr>
- <tr><td>hsCRP</td><td>每2-3年</td><td>炎症水平标志物</td></tr>
- <tr><td>颈动脉超声</td><td>高危人群每年</td><td>早期斑块检测</td></tr>
- <tr><td>心电图(静息)</td><td>每年</td><td>心脏基础状态</td></tr>
- </table>
- </div>
- </div>
- <div>
- <div class="card card-teal">
- <h3>🧬 基因检测:风险背景参考</h3>
- <p>有早发冠心病/脑卒中家族史(一级亲属男性<55岁、女性<65岁)的人群建议进行基因检测:</p>
- <ul class="list-styled green">
- <li><strong>apoE基因型</strong>:ε4携带者心血管病风险↑约40%</li>
- <li><strong>9p21.3风险位点</strong>:心血管遗传风险位点</li>
- <li><strong>LPA基因变异</strong>:脂蛋白(a)升高,独立风险因子</li>
- <li><strong>AGT/ADD1基因</strong>:盐敏感基因型,限盐更严格</li>
- <li><strong>PCSK9功能变异</strong>:影响LDL-C代谢</li>
- </ul>
- <p style="margin-top:0.5rem;color:var(--text-muted);font-size:0.82rem;">基因是风险背景,不是判决书。高遗传风险 = 更积极干预的指征。</p>
- </div>
- <div class="card card-purple" style="margin-top:1.25rem;">
- <h3>⚠️ 重点识别信号</h3>
- <p>一级亲属早发心血管病(男<55岁,女<65岁)提示遗传风险较高。此外,<strong>女性PCOS</strong>和<strong>男性勃起功能障碍(ED)</strong>均是心血管病风险升高的独立信号,提示内皮功能已受损。</p>
- </div>
- </div>
- </div>
- <!-- STEP 02 -->
- <h3 style="font-size:1.15rem;font-weight:700;margin:2rem 0 1rem;color:var(--teal);">② 风险管控——分层管理,有的放矢</h3>
- <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">
- 根据评估结果进行分层:低危以生活方式干预为主;中危生活方式+考虑药物;高危(已患心血管病、糖尿病、慢性肾病)需要药物+生活方式双管齐下,目标值更严格。
- </p>
- <div class="table-wrap" style="margin-bottom:1.5rem;">
- <table>
- <tr><th>风险级别</th><th>判断标准</th><th>LDL-C目标</th><th>血压目标</th><th>核心策略</th></tr>
- <tr><td><strong>低危</strong></td><td>10年风险 <5%(China-PAR)</td><td><3.4 mmol/L</td><td><140/90 mmHg</td><td>强化生活方式干预</td></tr>
- <tr><td><strong>中危</strong></td><td>10年风险 5-20%</td><td><2.6 mmol/L</td><td><130/80 mmHg</td><td>生活方式+考虑他汀</td></tr>
- <tr><td><strong>高危</strong></td><td>10年风险≥20%,或糖尿病/CKD</td><td><1.8 mmol/L</td><td><130/80 mmHg</td><td>他汀+生活方式双管</td></tr>
- <tr><td><strong>极高危</strong></td><td>已患ASCVD</td><td><1.4 mmol/L</td><td><130/80 mmHg</td><td>强化药物治疗</td></tr>
- </table>
- </div>
- <p style="color:var(--text-muted);font-size:0.82rem;margin-bottom:1rem;">参考:《中国血脂管理指南2023》《中国高血压防治指南2023》</p>
- <div class="evidence-box blue" style="margin-bottom:1.5rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">📊 为什么LDL-C是"硬终点"?</span>
- <span class="ev-tag blue">他汀RCT证据</span>
- </div>
- <p><strong>LDL-C每降低1mmol/L,主要心血管事件风险降低约20-25%</strong>。这一效果在不同患者群体中一致存在(无论有无心血管病、是否合并糖尿病)。对于中危以上人群,降脂治疗(首选他汀)是减少心血管事件最有力的药物干预,配合生活方式改变效果更佳。</p>
- </div>
- <!-- STEP 03 -->
- <h3 style="font-size:1.15rem;font-weight:700;margin:2rem 0 1rem;color:var(--purple);">③ 主动干预——可执行的五维干预策略</h3>
- <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">
- 主动干预不是"少吃、多动"的口号,而是需要具体化、可量化、可坚持的行动方案。五个维度同时发力,效果最为显著。
- </p>
- <div class="grid-2" style="margin-bottom:1.5rem;">
- <div>
- <div class="card card-purple" style="margin-bottom:1.25rem;">
- <span class="card-icon">🥗</span>
- <h3>饮食干预——心血管健康的基石</h3>
- <p><strong>地中海饮食(Mediterranean Diet):</strong>特征:高比例橄榄油、坚果、全谷物、蔬菜、水果;适量鱼类和禽肉;限制红肉和甜饮料。PREDIMED研究(7447人,随访5年)显示:地中海饮食+坚果/橄榄油,心血管事件风险降低约26-30%。</p>
- <p style="margin-top:0.5rem;"><strong>DASH饮食:</strong>专门为降压设计的饮食模式——高水果蔬菜、低脂乳制品、限盐限饱和脂肪。效果:收缩压平均降低约11mmHg,接近单药降压治疗。</p>
- <p style="margin-top:0.5rem;"><strong>实操要点:</strong>每日盐摄入<5g;每日红肉<100g;每日膳食纤维>25g;每周吃鱼≥2次;用橄榄油/菜籽油替代动物油;避免反式脂肪。</p>
- </div>
- <div class="card card-orange" style="margin-bottom:1.25rem;">
- <span class="card-icon">🏃</span>
- <h3>运动干预——改善内皮的"天然药物"</h3>
- <p>规律运动改善血管内皮功能(↑NO生物利用度)、降低血压、改善血脂、减轻炎症。EPI NCS研究:每周150分钟中等强度有氧运动(快走)可降低心血管死亡风险约20%。</p>
- <p style="margin-top:0.5rem;"><strong>运动处方:</strong>有氧:每周≥150分钟中等强度或75分钟高强度;抗阻运动:每周2-3次;柔韧性训练:每周拉伸;<strong>每坐1小时起身活动5分钟</strong>(久坐危害无法被运动完全抵消)。</p>
- </div>
- <div class="card card-blue">
- <span class="card-icon">💧</span>
- <h3>富氢水——改善内皮的新兴手段</h3>
- <p>富氢水(Electrolyzed Hydrogen Water)通过选择性中和·OH和ONOO⁻等强氧化剂,降低氧化应激,改善内皮功能。</p>
- <p style="margin-top:0.5rem;"><strong>核心证据:</strong>IJMS 2024系统综述(doi:10.3390/ijms25020973,12项临床研究):富氢水显著改善血流介导的血管舒张功能(FMD)。高血压大鼠饮用4周:收缩压↓约15mmHg,ox-LDL↓,SOD↑,MDA↓,eNOS磷酸化↑(NO合成恢复)。</p>
- <p style="margin-top:0.5rem;"><strong>实操:</strong>每日饮用1.5-2L(电解>30分钟的仪器产水效果更稳定),配合饮食运动,不替代药物。</p>
- </div>
- </div>
- <div>
- <div class="card card-accent" style="margin-bottom:1.25rem;">
- <span class="card-icon">🚭</span>
- <h3>戒烟——最具性价比的单一干预</h3>
- <p>戒烟后心血管获益出现极快:戒烟1年风险降低约50%;戒烟5-15年风险接近从不吸烟者。二手烟同样增加不吸烟者约25%心血管病风险。</p>
- <p style="margin-top:0.5rem;"><strong>戒烟方法:</strong>心理支持+药物辅助(尼古丁替代疗法、安非他酮、伐尼克兰)是最有效方案。<strong>电子烟含尼古丁</strong>,对内皮功能有损害,不推荐作为戒断辅助。</p>
- </div>
- <div class="card card-teal" style="margin-bottom:1.25rem;">
- <span class="card-icon">🧘</span>
- <h3>压力管理与睡眠——被低估的手段</h3>
- <p><strong>慢性心理压力:</strong>通过交感神经激活升高血压、血糖和炎症水平。应对方法:正念冥想(每日10-20分钟,研究显示可降低收缩压约3-7mmHg)、有氧运动、充足睡眠。</p>
- <p style="margin-top:0.5rem;"><strong>睡眠:</strong>睡眠不足(<6小时/天)和睡眠呼吸暂停综合征(OSAS)是高血压的独立风险因素。目标睡眠时长:7-9小时/天,入睡<30分钟。</p>
- </div>
- <div class="card card-purple">
- <span class="card-icon">🦠</span>
- <h3>肠道菌群调节——从TMAO通路源头干预</h3>
- <p><strong>降低TMAO:</strong>减少红肉(肉碱)和蛋黄(胆碱)摄入;增加膳食纤维(促进产SCFAs细菌生长,间接竞争性抑制产TMA细菌);规律运动;某些益生菌株已被证实可降低TMAO水平。</p>
- <p style="margin-top:0.5rem;"><strong>升高SCFAs:</strong>每日膳食纤维>25g(全谷物、杂豆、蔬菜、水果);发酵食品(酸奶、泡菜、纳豆);规律运动同样增加产SCFAs肠道菌群丰度。</p>
- </div>
- </div>
- </div>
- <!-- STEP 04 -->
- <h3 style="font-size:1.15rem;font-weight:700;margin:2rem 0 1rem;color:var(--orange);">④ 效果评估——用数据说话,验证干预是否有效</h3>
- <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">
- 主动健康不是"做了就好",而是要量化效果、动态调整。建立个人健康数据追踪体系,是效果评估的核心工具。
- </p>
- <div class="grid-2" style="margin-bottom:1.5rem;">
- <div class="card card-orange">
- <h3>📊 需要追踪的核心指标</h3>
- <table>
- <tr><th>指标</th><th>目标值</th><th>测量频率</th></tr>
- <tr><td>血压</td><td><130/80 mmHg(高危)</td><td>家庭自测每周3-7次</td></tr>
- <tr><td>LDL-C</td><td>根据风险级别</td><td>每3-6个月</td></tr>
- <tr><td>HDL-C</td><td>男>1.0, 女>1.3 mmol/L</td><td>每年</td></tr>
- <tr><td>甘油三酯</td><td><1.7 mmol/L</td><td>每年</td></tr>
- <tr><td>空腹血糖</td><td><5.6 mmol/L</td><td>每年</td></tr>
- <tr><td>HbA1c</td><td><7%(糖尿病患者)</td><td>每3-6个月</td></tr>
- <tr><td>BMI</td><td>18.5-23.9 kg/m²</td><td>每年</td></tr>
- <tr><td>腰围</td><td>男<90cm,女<85cm</td><td>每年</td></tr>
- <tr><td>hsCRP</td><td><1 mg/L(理想)</td><td>每6-12个月</td></tr>
- </table>
- </div>
- <div class="card card-teal">
- <h3>🩺 定期专科检查(根据风险级别)</h3>
- <ul class="list-styled green">
- <li><strong>颈动脉超声</strong>:评估IMT和斑块,高危人群每年1次</li>
- <li><strong>冠脉CTA</strong>:评估冠脉钙化积分,高危无症状人群每3-5年</li>
- <li><strong>踝臂指数(ABI)</strong>:评估下肢动脉硬化,50岁以上或吸烟者每年</li>
- <li><strong>眼底检查</strong>:高血压/糖尿病患者每年1次</li>
- <li><strong>尿微量白蛋白</strong>:高血压/糖尿病肾损害早期指标</li>
- <li><strong>心脏超声</strong>:高血压/心衰患者每1-2年</li>
- </ul>
- <p style="margin-top:0.75rem;font-size:0.85rem;color:var(--text-muted);">建立个人健康档案,追踪趋势变化。这帮助医生了解你的长期健康轨迹,也帮助你建立对自身健康的主动掌控感。</p>
- </div>
- </div>
- <div class="evidence-box green" style="margin-bottom:1.5rem;">
- <div class="evidence-box-header">
- <span class="evidence-box-title">📊 干预效果的预期幅度(RCT数据)</span>
- <span class="ev-tag green">循证数据</span>
- </div>
- <p>限盐(每日<5g):收缩压降低约5-8mmHg(高血压患者)|DASH饮食:收缩压降低约11mmHg|规律有氧运动(每周150分钟):收缩压降低约5mmHg,LDL-C降低约5-10%|减重(每减10kg):收缩压降低约5-20mmHg|他汀治疗(中等强度):LDL-C降低约30-50%|富氢水:FMD改善约2-4%(相对值)。</p>
- </div>
- <!-- STEP 05 -->
- <h3 style="font-size:1.15rem;font-weight:700;margin:2rem 0 1rem;color:var(--teal);">⑤ 持续优化——把健康当作长期投资</h3>
- <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">
- 心脑血管健康不是"达标后就停止"的事。动脉粥样硬化是慢性进展性疾病,需要终身管理。持续优化意味着:根据评估结果动态调整方案,在不同人生阶段采取与年龄匹配的策略,并不断迭代最新的科学证据。
- </p>
- <div class="grid-3">
- <div class="card card-blue">
- <h3>👤 分年龄段策略</h3>
- <p><strong>20-35岁(预防黄金期)</strong>:建立健康习惯;了解家族史;基线体检;接种流感疫苗。</p>
- <p style="margin-top:0.4rem;"><strong>35-50岁(风险积累期)</strong>:每年体检;识别糖尿病前期;关注颈动脉IMT;开始地中海饮食模式。</p>
- <p style="margin-top:0.4rem;"><strong>50-65岁(疾病高发期)</strong>:强化危险因素管理;关注心电图和心脏超声;识别心衰早期信号。</p>
- <p style="margin-top:0.4rem;"><strong>65岁以上(康复维持期)</strong>:心脏康复指导下运动;防跌倒;保持社交活动。</p>
- </div>
- <div class="card card-purple">
- <h3>🔄 动态调整机制</h3>
- <p>每3-6个月进行一次"主动健康回顾":① 上阶段干预措施执行情况如何?② 指标变化趋势是向好还是向坏?③ 遇到哪些障碍?④ 下阶段需要调整什么?</p>
- <p style="margin-top:0.5rem;"><strong>遇到瓶颈时的思路:</strong>降压/降脂效果不佳→联合用药;运动依从性差→从每天5分钟开始逐步增加;饮食难以坚持→寻找替代方案(不同口感/烹饪方式);压力管理无效→寻求心理咨询。</p>
- <p style="margin-top:0.5rem;color:var(--text-muted);font-size:0.85rem;"><strong>重要原则:</strong>没有"完美方案",只有"当前最优方案"。小幅改善+长期坚持,优于完美方案+短期放弃。</p>
- </div>
- <div class="card card-orange">
- <h3>👨👩👧👦 家庭健康管理</h3>
- <p>心脑血管健康是家庭共同的事业:</p>
- <ul class="list-styled">
- <li>家庭共餐:地中海饮食模式的最佳实践场景</li>
- <li>全家运动:周末徒步、骑行、家庭运动时间</li>
- <li>互相提醒:戒烟监督、按时服药、定期体检</li>
- <li>家庭健康档案:记录每个人的关键指标趋势</li>
- <li>儿童健康教育:从青少年期建立心血管健康意识</li>
- </ul>
- </div>
- </div>
- <div class="quote-block green" style="margin-top:2rem;">
- <p class="quote-text">"主动健康不是要求你成为一个'完美健康人',而是让你在力所能及的范围内,做出对心血管系统最友好的选择。每一个小的改善——少吃一勺盐、多走10分钟路、少抽一根烟——都在累积对心血管系统的保护效应。持之以恒,效果惊人。"</p>
- <span class="quote-source">— 浠艾福 · 主动健康学院 · 五维幸福理念</span>
- </div>
- </div>
- </section>
- <!-- CTA -->
- <section class="cta-section">
- <div class="container">
- <h2>主动健康,从今天开始</h2>
- <p>心脑血管疾病可预防、可延缓、可管理。用科学的知识武装自己,用主动的行动保护家人。<br>在基因给定的底牌上,通过生活方式干预,你完全有能力改写自己的心血管命运。</p>
- <div class="cta-buttons">
- <a href="index.html" class="btn btn-primary">🏠 返回首页</a>
- <a href="https://www.etotem.com.cn" class="btn btn-outline" target="_blank">了解主动健康服务</a>
- </div>
- </div>
- </section>
- <!-- Footer (shared) -->
- <div id="footer-placeholder"></div>
- <script src="js/footer.js"></script>
- <!-- ══════════════════════════════════════════
- 参考文献
- ═══════════════════════════════════════════ -->
- <section class="citations" id="citations">
- <div class="container">
- <h2 style="font-size:1.3rem;font-weight:800;margin-bottom:1.5rem;display:flex;align-items:center;gap:0.5rem;">📚 参考文献</h2>
- <div class="citation-card" id="ref-1">
- <div class="source">[1] 《中国心血管健康与疾病报告2024》· 中国循环杂志</div>
- <div class="auth-row"><span class="auth-badge blue">📊 中国官方流行病学数据</span></div>
- <div class="findings">中国心血管病患病率现患人数达3.45亿,高血压患者2.45亿,年死亡458万。城乡居民死亡原因首位。</div>
- <div class="trans">中国心血管健康与疾病报告2024——中国心血管病流行现状与防治策略的核心文献</div>
- </div>
- <div class="citation-card" id="ref-2">
- <div class="source">[2] Physiological Reviews · Otsuka et al. · 2023 · doi:10.1152/physrev.00024.2022</div>
- <div class="auth-row"><span class="auth-badge">📚 生理学评论 · IF 20.3</span><span class="auth-badge purple">GWAS里程碑</span></div>
- <div class="findings">GWAS and Cardiovascular Disease. 500+ GWAS studies, 1.5M+ subjects, 1500+ genetic loci. Most CVD genetic risk acts through upstream regulation of modifiable risk factors — lifestyle intervention can change outcomes even with high genetic risk.</div>
- <div class="trans">心血管遗传学系统综述——综合500+GWAS研究、150万受试者数据,证实心血管遗传风险通过可改变危险因素的上游调控发挥作用</div>
- <a class="link" href="https://doi.org/10.1152/physrev.00024.2022" target="_blank">🔗 doi.org/10.1152/physrev.00024.2022</a>
- </div>
- <div class="citation-card" id="ref-3">
- <div class="source">[3] Frontiers in Cardiovascular Medicine · Harshfield et al. · 2022 · PMC9268449</div>
- <div class="auth-row"><span class="auth-badge green">🧬 肠道菌群-心血管轴 · 系统综述</span></div>
- <div class="findings">The Gut-Heart Axis. TMAO pathway drives atherosclerosis (↑60% CV events); SCFAs (acetate/propionate/butyrate) protect via GPR41/43 receptors; bile acid FXR/TGR5 signaling regulates cardiometabolic health.</div>
- <div class="trans">肠-心轴:TMAO通路(促硬化,↑60%心血管事件风险)和SCFAs保护通路(抗炎、内皮保护)的系统综述</div>
- <a class="link" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268449/" target="_blank">🔗 PMC9268449</a>
- </div>
- <div class="citation-card" id="ref-4">
- <div class="source">[4] IJMS · Zanardo et al. · 2024 · doi:10.3390/ijms25020973</div>
- <div class="auth-row"><span class="auth-badge green">💧 富氢水系统综述 · IJMS IF 5.6 · 12项临床研究</span></div>
- <div class="findings">Electrolysed Hydrogen Water and Cardiovascular Health. EHW significantly improves FMD, reduces ox-LDL, increases SOD activity, decreases MDA, restores eNOS phosphorylation. H₂ selectively neutralizes ·OH and ONOO⁻, activates Nrf2, inhibits NLRP3.</div>
- <div class="trans">电解富氢水与心血管健康系统综述——富氢水通过选择性中和强氧化剂、激活Nrf2、恢复eNOS,显著改善内皮功能</div>
- <a class="link" href="https://doi.org/10.3390/ijms25020973" target="_blank">🔗 doi.org/10.3390/ijms25020973</a>
- </div>
- <div class="citation-card" id="ref-5">
- <div class="source">[5] Lancet · Yusuf et al. · 2004 · INTERHEART · doi:10.1016/S0140-6736(04)17018-9</div>
- <div class="auth-row"><span class="auth-badge">📊 全球52国 · n=15000+15000 · 循证里程碑</span></div>
- <div class="findings">9 modifiable risk factors account for >90% of PAR for acute MI: dyslipidemia 49.2%, smoking 35.7%, diabetes 25.7%, hypertension 25.0%, abdominal obesity 20.1%, psychosocial factors 16.5%, fruit/veg deficiency 13.7%, physical inactivity 12.2%, alcohol 5.0%.</div>
- <div class="trans">INTERHEART研究——全球52国30000人的里程碑研究,证实90%以上的心肌梗死归因于9个可改变危险因素</div>
- <a class="link" href="https://doi.org/10.1016/S0140-6736(04)17018-9" target="_blank">🔗 doi.org/10.1016/S0140-6736(04)17018-9</a>
- </div>
- <div class="citation-card" id="ref-6">
- <div class="source">[6] NEJM · Ridker et al. · 2017 · CANTOS · doi:10.1056/NEJMoa1707914</div>
- <div class="auth-row"><span class="auth-badge">🔬 RCT · IL-1β靶点 · NEJM IF 176</span><span class="auth-badge green">抗炎治疗里程碑</span></div>
- <div class="findings">Canakinumab reduced CV events by ~15% independent of lipid-lowering, proving inflammation is a valid CVD treatment target beyond lipid management.</div>
- <div class="trans">CANTOS研究——首个证明抗炎治疗可独立于降脂之外降低心血管事件的RCT,证实动脉粥样硬化的炎症本质</div>
- <a class="link" href="https://doi.org/10.1056/NEJMoa1707914" target="_blank">🔗 doi.org/10.1056/NEJMoa1707914</a>
- </div>
- <div class="citation-card" id="ref-7">
- <div class="source">[7] NEJM · Estruch et al. · 2013 · PREDIMED · doi:10.1056/NEJMoa1200303</div>
- <div class="auth-row"><span class="auth-badge">🥗 RCT · n=7447 · 随访5年</span></div>
- <div class="findings">Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major CV events by 26-30% vs low-fat control diet in 7447 high-risk participants.</div>
- <div class="trans">PREDIMED研究——地中海饮食(加额外橄榄油或坚果)使高危人群心血管事件风险降低26-30%,迄今最强的饮食干预RCT证据</div>
- <a class="link" href="https://doi.org/10.1056/NEJMoa1200303" target="_blank">🔗 doi.org/10.1056/NEJMoa1200303</a>
- </div>
- <div class="citation-card" id="ref-8">
- <div class="source">[8] Circulation · Cook et al. · 2015 · TOHP · doi:10.1161/CIRCULATIONAHA.114.012671</div>
- <div class="auth-row"><span class="auth-badge">🧂 限盐研究 · 15年随访</span></div>
- <div class="findings">Sodium reduction of 4.6g/day: systolic BP ↓~5mmHg (normotensive), ~7mmHg (hypertensive); 25% reduction in CV events at 15-year follow-up.</div>
- <div class="trans">TOHP研究15年随访——每日盐摄入减少4.6g可降低心血管事件风险约25%,限盐保护心血管的最强长期随访证据</div>
- <a class="link" href="https://doi.org/10.1161/CIRCULATIONAHA.114.012671" target="_blank">🔗 doi.org/10.1161/CIRCULATIONAHA.114.012671</a>
- </div>
- <div class="citation-card" id="ref-9">
- <div class="source">[9] 中华高血压杂志 · 中国高血压防治指南修订委员会 · 2023</div>
- <div class="auth-row"><span class="auth-badge blue">📋 中国高血压防治指南2023</span></div>
- <div class="findings">更新高血压诊断标准(≥130/80mmHg)和分层管理策略,推荐家庭血压监测(HBPM)和24小时动态血压监测(ABPM)。</div>
- <div class="trans">中国高血压防治指南2023——中国高血压诊断、分级、治疗和管理的权威指南</div>
- </div>
- <div class="citation-card" id="ref-10">
- <div class="source">[10] European Heart Journal · Mach et al. · 2020 · doi:10.1093/eurheartj/ehz455</div>
- <div class="auth-row"><span class="auth-badge blue">📋 欧洲血脂管理指南2019</span></div>
- <div class="findings">LDL-C goals stratified by risk: very high risk <1.4 mmol/L; high risk <1.8 mmol/L; moderate risk <2.6 mmol/L. LDL-C each 1mmol/L reduction = ~20-25% CV event reduction.</div>
- <div class="trans">2019 ESC/EAS血脂管理指南——根据风险分层设定LDL-C目标值,强调LDL-C是ASCVD核心驱动因子</div>
- <a class="link" href="https://doi.org/10.1093/eurheartj/ehz455" target="_blank">🔗 doi.org/10.1093/eurheartj/ehz455</a>
- </div>
- <div class="citation-card" id="ref-11">
- <div class="source">[11] Science Translational Medicine · Ko et al. · 2022 · doi:10.1126/scitranslmed.abn4703</div>
- <div class="auth-row"><span class="auth-badge green">🧬 肠菌干预 · IF 19.3</span></div>
- <div class="findings">Targeting the gut microbiome to treat CVD. Dietary L-carnitine (red meat) → TMA → TMAO → atherosclerosis and platelet hyperreactivity. Interventions: reduce red meat, increase fiber, exercise, specific probiotics.</div>
- <div class="trans">肠菌靶向治疗心血管病——阐述TMAO通路的完整链条以及通过饮食、运动和益生菌干预TMAO的策略</div>
- <a class="link" href="https://doi.org/10.1126/scitranslmed.abn4703" target="_blank">🔗 doi.org/10.1126/scitranslmed.abn4703</a>
- </div>
- </div>
- </section>
- </body>
- </html>
|